Troxerutin - Inpharma SA

Drug Profile

Troxerutin - Inpharma SA

Alternative Names: IN-001; Troxerutine - Inpharma SA; Troxerutine topical

Latest Information Update: 18 Mar 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inpharma SA
  • Class Vascular disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Erectile dysfunction

Most Recent Events

  • 18 Mar 2002 No development reported - Phase-III for Erectile dysfunction in France (Topical)
  • 20 Jul 1999 New profile
  • 20 Jul 1999 Phase-III clinical trials for Erectile dysfunction in France (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top